Marc S. Sabatine
Marc S. Sabatine
TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School
確認したメール アドレス: partners.org
タイトル
引用先
引用先
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
12983*2017
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on …
RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin, RA Guyton, ...
Journal of the American College of Cardiology 63 (22), e57-e185, 2014
7797*2014
Heart disease and stroke statistics—2013 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
circulation 127 (1), e6-e245, 2013
74142013
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
DC Goff, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, R Gibbons, ...
Journal of the American College of Cardiology 63 (25 Part B), 2935-2959, 2014
49842014
2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association …
EA Amsterdam, NK Wenger, RG Brindis, DE Casey, TG Ganiats, ...
Journal of the American College of Cardiology 64 (24), e139-e228, 2014
4517*2014
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England Journal of Medicine 376 (18), 1713-1722, 2017
34212017
Cytochrome p-450 polymorphisms and response to clopidogrel
JL Mega, SL Close, SD Wiviott, L Shen, RD Hockett, JT Brandt, JR Walker, ...
New England journal of medicine 360 (4), 354-362, 2009
27972009
The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease
PG Hagan, CA Nienaber, EM Isselbacher, D Bruckman, DJ Karavite, ...
Jama 283 (7), 897-903, 2000
26942000
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
26452005
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
26262019
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
23792020
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA De Lemos, DA Morrow, JH Bentley, T Omland, MS Sabatine, ...
New England Journal of Medicine 345 (14), 1014-1021, 2001
19662001
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American …
GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn, LA Fleisher, ...
Journal of the American College of Cardiology 68 (10), 1082-1115, 2016
18382016
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
18322019
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
16142015
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
15912011
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
13672015
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome …
TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich, MP Bonaca, ...
The Lancet 393 (10166), 31-39, 2019
13282019
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis
JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ...
Jama 304 (16), 1821-1830, 2010
11592010
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
ML O'Donoghue, E Braunwald, EM Antman, SA Murphy, ER Bates, ...
The Lancet 374 (9694), 989-997, 2009
9832009
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20